Skip to main navigation Skip to search Skip to main content

Secukinumab attenuates neuroinflammation and neurobehavior defect via PKCβ/ERK/NF-κB pathway in a rat model of GMH

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number114276
JournalExperimental Neurology
Volume360
DOIs
StatePublished - Feb 2023

ASJC Scopus Subject Areas

  • Neurology
  • Developmental Neuroscience

Keywords

  • GMH
  • IL-17A
  • Neurobehavior
  • Neuroinflammation
  • Secukinumab
  • Animals, Newborn
  • Animals
  • NF-kappa B
  • Neuroinflammatory Diseases
  • Cerebral Hemorrhage/metabolism
  • Rats
  • Rats, Sprague-Dawley

Cite this